Molecular signaling pathways regulating muscle proteolysis during atrophy

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 8, Issue 3, 2005, Pages 271-275

  Franch, Harold A ^a,b   Price, S Russ ^a  

^a EMORY UNIVERSITY   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Atrophy; Insulin like growth factor 1; Proteasome; Protein degradation; Skeletal muscle; Ubiquitin

Indexed keywords

ACTIN; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; UBIQUITIN PROTEIN LIGASE E3;

ATTENUATION; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 17844399802     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mco.0000165005.01331.45     Document Type: Review

References (51)

1. Kotler DP. Cachexia. Ann Intern Med 2000; 133:622-634.
2. Mitch WE, Goldberg AL. Mechanisms of muscle wasting: the role of the ubiquitin-proteasome pathway. N Engl J Med 1996; 335:1897-1905.
3. Florini JR, Ewton DZ, Coolican SA. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 1996; 17:481-517.
4. Mitchell PO, Pavlath GK. Skeletal muscle atrophy leads to loss and dysfunction of muscle precursor cells. Am J Physiol Cell Physiol 2004; 287:C1753-C1762. After demonstrating that muscle precursor cells from atrophic muscle fail to grow properly or fuse into myotubes, this paper discusses the mechanisms underlying the change in phenotype.
5. Guttridge DC. Signaling pathways weigh in on decisions to make or break skeletal muscle. Curr Opin Clin Nutr Metab Care 2004; 7:443-450. A concise review on the regulation of muscle size by Akt, NFκB and myostatin with an emphasis on protein synthesis.
6. Bodine SC, Stitt TN, Gonzalez M, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 2001; 3:1014-1019.
7. Smith OL, Wong CY, Gelfand RA. Influence of glucocorticoids on skeletal muscle proteolysis in normal and diabetic-adrenalectomized eviscerated rats. Metabolism 1990; 39:641-646.
8. Chrysis D, Underwood LE. Regulation of components of the ubiquitin system by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone. Endocrinology 1999; 140:5635-5641.
9. Mitch WE, Bailey JL, Wang X, et al. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. Am J Physiol 1999; 276:C1132-C1138.
10. Price SR, Bailey JL, Wang X, et al. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest 1996; 98:1703-1708.
11. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004; 287:C834-C843. A comprehensive review of the molecular triggers and signaling pathways that lead to muscle atrophy caused by disuse.
12. Acharyya S, Ladner KJ, Nelsen LL, et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 2004; 114:370-378. An in-depth examination of the core myofibrillar proteins and how their level is regulated in cell culture and tumor models of muscle atrophy. The paper concludes that wasting caused by cancer does not result from a general downregulation of muscle proteins but rather a selective targeting process.
13. Frost RA, Nystrom GJ, Lang CH. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway. Endocrinology 2003; 144:1770-1779. This paper investigates the inflammatory cytokine-induced suppression of IGF-1 in the muscle precursor cell model as a mechanism of muscle atrophy.
14. Mitch WE, Price SR. Mechanisms activating proteolysis to cause muscle atrophy in catabolic conditions. J Renal Nutr 2003; 13:149-152. A concise review of muscle atrophy in the context of renal diseases.
15. Pickart CM. Back to the future with ubiquitin. Cell 2004; 116:181-190. A perspective that reviews the impact of early papers describing ubiquitin-mediated signaling system and highlights important insights since those papers.
16. Jagoe RT, Lecker SH, Gomes M, Goldberg AL. Patterns of gene expression in atrophying skeletal muscles: response to food deprivation. FASEB J 2002; 16:1697-1712.
17. Lecker SH, Jagoe RT, Gilbert A, et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 2004; 18:39-51. This paper describes the use of microarrays to analyse changes in muscle gene expression caused by fasting, cancer, diabetes, and kidney failure. The study identified a common set of genes (i.e. atrogins) that are increased or decreased in all four models of muscle atrophy.
18. Stevenson EJ, Giresi PG, Koncarevic A, Kandarian SC. Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle. J Physiol 2003; 551:33-48. A microarray-based analysis of the changes in gene expression during muscle atrophy caused by hindlimb suspension.
19. Lecker SH, Solomon V, Price SR, et al. Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. J Clin Invest 1999; 104:1411-1420.
20. Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294:1704-1708.
21. Gomes MD, Lecker SH, Jagoe RT, et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 2001; 98:14440-14445.
22. Kwak KS, Zhou X, Solomon V, et al. Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3{alpha}-II during cancer cachexia. Cancer Res 2004; 64:8193-8198. This paper reports the identification of a muscle-specific E3 ubiquitin ligase that is closely related to E3a, the E3 enzyme that participates in the N-end rule. The paper is the first to test thoroughly the ubiquitin-conjugating activity of a muscle-specific E3 ligase.
23. Li HH, Kedar V, Zhang C, et al. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 2004; 114:1058-1071. This paper is the first to identify calcineurin as a substrate for MAFbx/atrogin-1-mediated ubiquitin-conjugation in cardiomyocytes. The study highlights the inverse relationship between atrophy and hypertrophy.
24. Kedar V, McDonough H, Arya R, et al. Muscle-specific RING finger 1 is a bonafide ubiquitin ligase that degrades cardiac troponin I. Proc Natl Acad Sci USA 2004; 101:18135-18140. This paper identifies troponin as a substrate protein of the E3 ligase MuRF1 through a yeast two-hybrid screen. A function of MuRF1 in cardiohypertrophy is examined.
25. Arya R, Kedar V, Hwang JR, et al. Muscle ring finger protein-1 inhibits PKCa activation and prevents cardiomyocyte hypertrophy. J Cell Biol 2004; 167:1147-1159. MuRF1 was reported to be a key regulator of protein kinase C-dependent hypertrophic responses in cardiomyocytes. The paper identifies a second substrate of MuRF1, and therefore provides greater insights into the function of these key enzymes.
26. Franch HA, Raissi S, Wang X, et al. Acidosis impairs insulin receptor substrate-1-associated phosphoinositide 3-kinase signaling in muscle cells: consequences on proteolysis. Am J Physiol Renal Physiol 2004; 287:F700-F706. Metabolic acidosis, but not TNF-α, induces insulin resistance and accelerated proteasomal proteolysis in well-differentiated L6 myotubes. The effect was mimicked by inhibiting PI3K signaling.
27. Li BG, Hasselgren PO, Fang CH, Warden GD. Insulin-like growth factor-I blocks dexamethasone-induced protein degradation in cultured myotubes by inhibiting multiple proteolytic pathways: 2002 ABA paper. J Burn Care Rehabil 2004; 25:112-118. This paper examines proteolytic pathways affected when IGF-1 reverses the effect of dexamethasone to stimulate proteolysis.
28. Lee SW, Dai G, Hu Z, et al. Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol 2004; 15:1537-1545. This paper examines the coordinated control of muscle atrophy in the L6 model by PI3K. Effects on apoptotic pathways such as bax and caspase 3 postulated to allow the ubiqination of myofibrillary protein are coordinated with decreases in atrogin1/MAFbx.
29. Dehoux M, Van Beneden R, Pasko N, et al. Role of IGF-1 decline in the induction of atrogin-1/MAFbx during fasting and diabetes. Endocrinology 2004; 145:4806-4812. This paper demonstrates that IGF-1 infusion blocks the increase in atrogin1/ MAFbx in diabetic animals.
30. Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL. IGF-1 stimulates muscle ® growth by suppressing protein breakdown and expression of atrophy-related ubiquitin-ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 2004; 287:E591-E601. This paper shows that the effect of IGF-1 to reverse the effect of dexamethasone on atrogin1/MAFbx and MuRF1 expression occurs via a PI3K-dependent pathway.
31. ••], was the first to show that IGF1/AKT and the FOXO transcription factors are required in vitro and in vivo for atrogin 1/MAFbx expression and muscle wasting.
32. ••]) was the first to show that AKT and FOXO transcription factors are required in vitro and in vivo for MuRF1 expression and muscle wasting.
33. Franch HA, Wang X, Sooparb S, et al. Phosphatidylinositol 3-kinase activity is required for epidermal growth factor to suppress proteolysis. J Am Soc Nephrol 2002; 13:903-909.
34. Petiot A, Ogier-Denis E, Blommaart EF, et al. Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 2000; 275:992-998.
35. Sooparb S, Price SR, Shaoguang J, Franch HA. Suppression of chaperone-mediated autophagy in the renal cortex during acute diabetes mellitus. Kidney Int 2004; 65:2135-2144. In contrast to skeletal muscle (where the activation of proteasomal proteolysis occurs), acute diabetes induces the suppression of lysosomal proteolysis in renal cells.
36. Kee AJ, Combaret L, Tilignac T, et al. Ubiquitin-proteasome-dependent muscle proteolysis responds slowly to insulin release and refeeding in starved rats. J Physiol 2003; 546:765-776. This paper examines the kinetics of proteolytic activation and the pathways that are activated.
37. Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004; 117:421-426. An excellent review of the multifaceted role of Foxos in cellular signaling. This article summarizes the important advances.
38. Lai KM, Gonzalez M, Poueymirou WT, et al. Conditional activation of Akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 2004; 24:9295-9304. An acute expression of an inducible constitutively active form of Akt in skeletal muscle results in hypertrophy. Activation of the p70S6 kinase pathway correlated with the hypertrophic response.
39. Kamei Y, Miura S, Suzuki M, et al. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem 2004; 279:41114-41123. This paper is the first to examine the role of FOXO1 in muscle growth and function using a transgenic mouse model. The studies provide insights into the changes in muscle structure and fiber type that occur during atrophy.
40. Jia K, Chen D, Riddle DL. The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 2004; 131:3897-3906. A study examining the interaction between insulin signaling pathways and mTOR in a model of organism development.
41. Downward J. PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 2004; 15:177-182. An informative review of the mechanisms by which insulin promotes cell survival.
42. Solomon V, Goldberg AL. Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem 1996; 271:26690-26697.
43. Solomon V, Lecker SH, Goldberg AL. The N-end rule pathway catalyzes a major fraction of the protein degradation in skeletal muscle. J Biol Chem 1998; 273:25216-25222.
44. Du J, Wang X, Miereles C, et al. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest 2004; 113:115-123. The paper demonstrates that caspase-3 participates in the degradation of actin in myofibrils. The paper highlights the role of caspase-3 in muscle atrophy.
45. Guttridge DC, Albanese C, Reuther JY, et al. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 1999; 19:5785-5799.
46. 20k expression is regulated by a mechanism involving NFκB.
47. Du J, Mitch WE, Wang X, Price SR. Glucocorticoids induce proteasome C3 subunit expression in L6 muscle cells by opposing the suppression of its transcription by NF-κB. J Biol Chem 2000; 275:19661-19666.
48. Whitehouse AS, Tisdale MJ. Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappaB. Br J Cancer 2003; 89:1116-1122. The paper examines how a novel tumor-associated protein, proteolysis-inducing factor, activates the ubiquitin-proteasome system.
49. Wyke SM, Russell ST, Tisdale MJ. Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation. Br J Cancer 2004; 91:1742-1750. A pharmacological inhibitor of NFκB prevents cancer-induced muscle atrophy in mice.
50. Cai D, Frantz JD, Tawa NE Jr, et al. IKKβNF-κB activation causes severe muscle wasting in mice. Cell 2004; 119:285-298. The transgenic expression of the activator of NBκB, the inhibitor of NFκB kinase, in mice caused muscle wasting and increased MuRF-1 expression. The inhibition of NFκB had the opposite effect.
51. Hunter RB, Kandarian SC. Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. J Clin Invest 2004; 114:1504-1511. Mice with a knockout of the gene encoding p105/p50 NFκB protein have less muscle wasting in a hindlimb unloading model.